Thrombotic thrombocytopenic purpura in an asplenic patient with hereditary spherocytosis: failure of plasmapheresis, antiplatelet therapy, and corticosteroids.

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a severe multisystem disorder characterized by microangiopathic hemolysis, central nervous system and renal dysfunction, and a very poor prognosis. Recently, however, plasma exchange or infusion therapy has proven effective in the majority of patients with TTP. We report a patient who developed TTP several years after splenectomy for hereditary spherocytosis. Despite aggressive therapy with plasmapheresis (PP), plasma infusion, antiplatelet drugs, and corticosteroids, the patient had progression of TTP that eventually resulted in his death. The occurrence of TTP in an asplenic patient with an intrinsic red cell disorder, a previously unreported association, may predict a poor prognosis.

• Authors: D L Becton, M Kletzel, W C Arnold, D H Berry
• Journal: The American journal of pediatric hematology/oncology (Am J Pediatr Hematol Oncol) Vol. 10 Issue 1 Pg. 5-8 ( 1988) ISSN: 0192-8562 [Print] United States
• PMID: 3189717 (Publication Type: Case Reports, Journal Article)

Chemical References

• Adrenal Cortex Hormones
• Platelet Aggregation Inhibitors

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Adult
• Humans
• Male
• Plasmapheresis
• Platelet Aggregation Inhibitors (therapeutic use)
• Purpura, Thrombotic Thrombocytopenic (etiology, therapy)
• Spherocytosis, Hereditary (complications, surgery)
• Splenectomy